Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment.

Taketo Suzuki,Tsutomu Mizoshita,Tomoya Sugiyama,Yoshikazu Hirata,Yoshihide Kimura,Yuka Suzuki,Tomonori Yamada,Hironobu Tsukamoto,Takashi Mizushima,Naomi Sugimura,Takahito Katano,Satoshi Tanida,Hiromi Kataoka,Makoto Sasaki

Case reports in gastroenterology（2019）

引用 12|浏览41

暂无评分

摘要

Adalimumab dose-escalation therapy is effective in refractory Crohn's disease patients with loss of response to adalimumab, especially in cases without previous infliximab treatment.

查看译文

关键词

Adalimumab dose escalation,Crohn's disease,Loss of response

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要